The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentamin PLC Regulatory News (CEY)

Share Price Information for Centamin PLC (CEY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.90
Bid: 122.80
Ask: 123.00
Change: -3.40 (-2.69%)
Spread: 0.20 (0.163%)
Open: 124.20
High: 125.90
Low: 122.60
Prev. Close: 126.30
CEY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Endeavour Mining Corporation

5 Dec 2019 15:00

RNS Number : 8426V
Citadel Group
05 December 2019
 

 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%

OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

(a) Full name of discloser:

Citadel Group

(b) Owner or controller of interests and short positions

disclosed, if different from 1(a):

The naming of nominee or vehicle companies is

insufficient. For a trust, the trustee(s), settlor and

beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant

securities this form relates:

Use a separate form for each offeror/offeree

ENDEAVOUR MINING CORP

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest

practicable date prior to the disclosure

04 December, 2019

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other

party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

CENTAMIN PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Convertible Bond ISIN US29257YAA29

Interests

Short Positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

26,835,000

8.13

0

0.00

(2) Cash-settled derivatives:

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

26,835,000

8.13

0

0.00

Class of relevant security:

Common Stock ISIN KYG3040R1589

Interests

Short Positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

12,915

0.01

639,926

0.58

(2) Cash-settled derivatives:

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

62,600

0.06

TOTAL:

12,915

0.01

702,526

0.64

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

Class of relevant security

ISIN KYG3040R1589

Purchase/sale

Number of securities

Price per unit

Common Stock

Purchase

100

24.75 CAD

Common Stock

Purchase

10,400

24.78634615 CAD

Common Stock

Purchase

300

24.79333333 CAD

Common Stock

Purchase

700

24.79857143 CAD

Common Stock

Purchase

200

24.8 CAD

Common Stock

Purchase

200

24.82 CAD

Common Stock

Purchase

1,500

24.85866667 CAD

Common Stock

Purchase

7,800

24.85987179 CAD

Common Stock

Purchase

200

24.86 CAD

Common Stock

Purchase

100

24.91 CAD

Common Stock

Purchase

700

24.91428571 CAD

Common Stock

Purchase

1,900

24.94526316 CAD

Common Stock

Purchase

200

24.995 CAD

Common Stock

Purchase

300

24.99666667 CAD

Common Stock

Purchase

300

25.01 CAD

Common Stock

Purchase

4,719

25.01420428 CAD

Common Stock

Purchase

1,200

25.02166667 CAD

Common Stock

Purchase

1,300

25.04615385 CAD

Common Stock

Purchase

7,600

25.06934211 CAD

Common Stock

Purchase

100

25.07 CAD

Common Stock

Purchase

4,600

25.08804348 CAD

Common Stock

Purchase

300

25.14 CAD

Common Stock

Purchase

800

25.1425 CAD

Common Stock

Purchase

100

25.18 CAD

Common Stock

Purchase

100

25.23 CAD

Common Stock

Purchase

100

25.24 CAD

Common Stock

Purchase

300

25.26666667 CAD

Common Stock

Purchase

100

25.32 CAD

Common Stock

Sale

-100

24.7 CAD

Common Stock

Sale

-2,500

24.766 CAD

Common Stock

Sale

-300

24.79 CAD

Common Stock

Sale

-100

24.82 CAD

Common Stock

Sale

-200

24.84 CAD

Common Stock

Sale

-200

24.8625 CAD

Common Stock

Sale

-800

24.874375 CAD

Common Stock

Sale

-100

24.89 CAD

Common Stock

Sale

-200

24.9075 CAD

Common Stock

Sale

-1,800

24.91583333 CAD

Common Stock

Sale

-300

24.92666667 CAD

Common Stock

Sale

-300

24.93 CAD

Common Stock

Sale

-500

24.934 CAD

Common Stock

Sale

-600

24.94 CAD

Common Stock

Sale

-400

24.9475 CAD

Common Stock

Sale

-4,585

24.95181461 CAD

Common Stock

Sale

-700

24.95571429 CAD

Common Stock

Sale

-4,200

24.97190476 CAD

Common Stock

Sale

-800

24.97375 CAD

Common Stock

Sale

-2,300

24.995 CAD

Common Stock

Sale

-1,800

25.00888889 CAD

Common Stock

Sale

-1,000

25.018 CAD

Common Stock

Sale

-200

25.02 CAD

Common Stock

Sale

-1,300

25.05423077 CAD

Common Stock

Sale

-11,900

25.0594958 CAD

Common Stock

Sale

-100

25.07 CAD

Common Stock

Sale

-800

25.07375 CAD

Common Stock

Sale

-8,700

25.08885057 CAD

Common Stock

Sale

-2,000

25.089 CAD

Common Stock

Sale

-4,437

25.10275411 CAD

Common Stock

Sale

-2,000

25.16825 CAD

Common Stock

Sale

-100

25.24 CAD

Common Stock

Sale

-100

25.3 CAD

(b) Cash-settled derivative transactions

Class of relevant security

 

ISIN

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

Class of relevant security

ISIN

KYG3040R1589

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Common

Put Option

Purchasing

-1,000

20 CAD

American

17/04/2020

0.75 CAD

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

 Date of disclosure:

05 December, 2019

 Contact name:

Katie Bonds

 Telephone number*:

020 7645 9700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1. KEY INFORMATION

Full name of person making disclosure:

Citadel Group

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

ENDEAVOUR MINING CORP

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

ISINKYG3040R1589

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common

Put Option

Purchased

-1000

20 CAD

American

17/04/2020

Common

Put Option

Purchased

-61600

17 DOL

American

17/01/2020

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETCKPDDDBDDOBK
Date   Source Headline
8th Dec 20207:00 amRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSDirector/PDMR Shareholding
2nd Dec 20207:00 amRNSUnlocking Centamin’s Potential – Market Event
2nd Dec 20207:00 amRNSOpen Pit Contract Award
25th Nov 20207:00 amRNSNOTIFICATION OF CAPITAL MARKETS EVENT
20th Nov 20207:11 amRNSNotification of Major Holding(s)
19th Nov 20204:40 pmRNSNotification of Major Holding(s)
18th Nov 20207:00 amRNSDirector Declaration
2nd Nov 20202:30 pmRNSDirector Declaration
29th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
21st Oct 20207:00 amRNSQ3 2020 Report
7th Oct 20207:00 amRNSNOTICE OF DIRECTOR DEALING
6th Oct 20207:00 amRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSSukari Operational Update
2nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
14th Aug 20207:00 amRNSNotice of New Website
4th Aug 20207:01 amRNS2020 Interim Results
4th Aug 20207:00 amRNSDividend Declaration
13th Jul 20207:00 amRNSQ2 2020 Report
7th Jul 20202:26 pmRNSNotification of Major Holding(s)
29th Jun 20202:34 pmRNSResult of 2020 Annual General Meeting
23rd Jun 20207:02 amRNS2019 Sustainability Report
23rd Jun 20207:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jun 20203:58 pmRNSNotification of Major Holding(s)
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
1st Jun 20207:13 amRNSAppointment of Non-Executive Director
27th May 20207:00 amRNSNotice of AGM & Publication of 2019 Annual Report
18th May 20207:01 amRNSPayments to Governments Report
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
11th May 20209:00 amRNSNotification of Full Year 2019 Results
11th May 20207:00 amRNSDirector Declaration
27th Apr 20207:00 amRNSDisclosure of Rights attached to Equity Shares
21st Apr 20207:00 amRNSQuarterly Report and Dividend Declaration
20th Apr 20205:34 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:00 amRNSDonation towards Egypt’s COVID-19 Relief Efforts
2nd Apr 20207:00 amRNSAppointment of CEO
25th Mar 20207:00 amRNSFCA Results Guidance and COVID-19 Update
24th Mar 20209:14 amRNSNotification of Major Holdings
25th Feb 20203:15 pmRNSForm 8.3 - Centamin PLC
21st Feb 20207:00 amRNSForm 8.3 - Centamin PLC
17th Feb 20207:00 amRNSForm 8.3 - Centamin PLC
7th Feb 20204:29 pmRNSForm 8.3 - Centamin PLC
4th Feb 202010:30 amRNSNotification of Major Holding(s)
30th Jan 20207:00 amRNSQ4 2019 Results
29th Jan 20207:00 amRNSForm 8.3 - Centamin PLC
28th Jan 202012:10 pmRNSNotification of Major Holding(s)
15th Jan 20203:20 pmRNSForm 8.3 - Centamin plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.